Open
SectorHealthcare
8.15 5.84
24h
Min
7.64
Max
8.2
Income | -173K -24M |
---|---|
Sales | 302K 3.1M |
Profit margin | -795.026 |
Employees | 102 |
EBITDA | -303K -23M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +345.84% upside |
Next Earnings | 12 lis 2025 |
---|
Market Cap | 9.1M 39M |
---|---|
Previous open | 2.31 |
Previous close | 8.15 |
By Acuity
34%
66%
97 / 371 Ranking in Healthcare
By Trading Central
Confidence
Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 35.4 USD 345.84%
High 50 USD
Low 17 USD
Based on 7 Wall Street analysts offering 12 month price targets forMersana Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$